Navigation Links
Elekta Announces Elekta Infinity - a New System for Faster and More Precise Treatment of Cancer Tumors
Date:10/29/2007

LOS ANGELES, Calif., Oct. 29 /PRNewswire/ -- Elekta, a global leader in radiation oncology and non-invasive neurosurgery solutions, announced Elekta Infinity*, the definitive new digital linear accelerator optimized for delivering Volumetric Intensity Modulated Arc Therapy* (VMAT), a very fast Intensity Modulated Radiation Therapy (IMRT) treatment delivered in single or multiple arcs, at the 49th Annual Meeting of The American Society for Therapeutic Radiology and Oncology (ASTRO). The meeting is being held October 28-November 1, at the Los Angeles Convention Center.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020318/ELEKTALOGO )

In the Elekta booth, Jay Hoey, Executive Vice President Product Creation at Elekta and CEO of IMPAC Medical Systems, announced the new Elekta Infinity, which more precisely targets tumors and protects surrounding healthy tissue, while drastically reducing radiation therapy treatment times.

"Elekta is committed to fighting serious disease and improving quality of life," says Hoey. "The Elekta Infinity with VMAT demonstrates this by benefiting patients with dramatically shorter treatment times and highly precise tumor targeting."

Elekta VMAT improves on IMRT technology

Utilizing Elekta's VMAT solution greatly improves on existing IMRT technologies and offers a faster alternative to helical tomotherapy. Elekta's VMAT solution, when used with Elekta Infinity, varies the radiation beam during treatment by simultaneously manipulating the gantry position and speed, MLC leaves, dose rate and collimator angle.

This provides several distinct advantages over current IMRT techniques, specifically the ability to deliver more radiation to the target while sparing healthy tissue in significantly less time than existing therapies. In addition, Elekta Infinity combines VMAT with VolumeView(TM) 3D cone beam imaging to create high-contrast images with ultra-low dose.

Patients benefit from faster treatments, reduced radiation

Elekta Infinity allows for a total VMAT treatment session in no more than five minutes, including true VolumeView(TM) 3D cone beam images in three minutes and two minutes of highly conformal arc delivery of radiation. Head and neck treatments -- including daily 3D imaging -- can be delivered in less than five minutes with Elekta Infinity. Coupled with the Elekta Infinity system's clinically proven ultra-low 3D imaging dose, the speed of VMAT treatments can reduce the whole body dose of patients receiving treatment. Elekta Infinity also protects patients with real-time control point to control point monitoring throughout the process.

Due to the ability of Elekta Infinity to also treat in non-coplanar angles and non trans-axial planes, the system can yield similar or improved dosimetric performance compared to helical tomotherapy.

More solutions from Elekta

In addition to Elekta Infinity, Elekta is exhibiting other solutions for boosting clinical efficiency at ASTRO. Elekta's complete stereotactic portfolio is featured, as well as innovative and time-saving products from the Elekta Group.

*Elekta Infinity and Volumetric Intensity Modulated Arc Therapy (VMAT) from Elekta are works in progress and not yet available for sale or distribution

About Elekta

Elekta is an international medical technology group, providing oncologists, radiation therapists, neurosurgeons and many other medical specialists with state of the art tools to fight serious disease.

Elekta provides advanced clinical solutions, comprehensive management and information systems as well as services for improved cancer care and management of brain disorders.

Elekta's systems and solutions are used in over 4,500 hospitals around the world. Clinical and information management solutions include, among others, Leksell Gamma Knife(R) for non-invasive treatment of brain disorders, Elekta Axesse(TM) and Elekta Synergy(R) for stereotactic and image guided radiation therapy and radiosurgery as well as the MOSAIQ(TM) suite of software for image-enabled EMR and efficient management of clinical and patient data.

With more than 2,000 employees globally, the corporate headquarter is located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb. More information about Elekta can be found at http://www.elekta.com.


'/>"/>
SOURCE Elekta, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... While the ... such as the Cary 5000 and the 6000i models are higher end machines that ... the height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... , June 23, 2016 A person commits ... the crime scene to track the criminal down. ... U.S. Food and Drug Administration (FDA) uses DNA evidence to ... Sound far-fetched? It,s not. The FDA has ... to support investigations of foodborne illnesses. Put as simply as ...
Breaking Biology Technology:
(Date:6/2/2016)... June 2, 2016 Perimeter Surveillance ... Unmanned Systems, Physical Infrastructure, Support & Other Service  ... visiongain offers comprehensive analysis of the global ... will generate revenues of $17.98 billion in 2016. ... Inc, a leader in software and hardware technologies for ...
(Date:5/24/2016)... superior patient care by providing unparalleled technology to leaders of the medical imaging industry. ... recently added to the range of products distributed by Ampronix. Photo - ... ... ... ...
(Date:5/16/2016)... May 16, 2016   EyeLock LLC , a ... the opening of an IoT Center of Excellence in ... expand the development of embedded iris biometric applications. ... of convenience and security with unmatched biometric accuracy, making ... aside from DNA. EyeLock,s platform uses video technology to ...
Breaking Biology News(10 mins):